Boothbay Fund Management’s Immunomedics Inc IMMU Stock Holding History

Boothbay Fund Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,301	Closed	-$366K	–	1600
2020 Q3	$366K	Buy	+4,301	New	+$218K	0.02%	758
2017 Q1	–	Sell	-13,593	Closed	-$68.9K	–	1009
2016 Q4	$50	Buy	+13,593	New	+$40.2K	0.01%	715

Boothbay Fund Management's IMMU Position: Q4 2020 in Review

Boothbay Fund Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 4,301 shares — an estimated $366K sold.

Boothbay Fund Management first reported a position in IMMU in Q4 2016 and held it in 2 quarters. The position peaked at $366K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Boothbay Fund Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Boothbay Fund Management sold 4,301 Immunomedics Inc shares in Q4 2020, an estimated $366K.
Boothbay Fund Management first reported a position in Immunomedics Inc in Q4 2016 and held it in 2 quarters.
Boothbay Fund Management's Immunomedics Inc position peaked at $366K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Boothbay Fund Management's 13F filing for Q4 2020, filed 12 Feb 2021.